» Articles » PMID: 35496781

Quantification of Unperturbed Phosphoprotein Levels in Immune Cell Subsets with Phosphoflow to Assess Immune Signaling in Autoimmune Disease

Overview
Journal STAR Protoc
Publisher Cell Press
Date 2022 May 2
PMID 35496781
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of innate immune sensors by endogenous DNA and RNA can lead to autoimmune and autoinflammatory diseases. Quantification of the unperturbed phosphoprotein content in immune cells provides insight into the spontaneous activity of immune signaling pathways triggered by nucleic acid recognition. Here, we present a phosphoflow protocol for measuring phosphoproteins in mouse models of autoimmunity that incorporates strategies to preserve native phosphoprotein levels during sample collection and to reliably detect low signaling activity common in chronic disease states. For complete details on the use and execution of this protocol, please refer to Jütte et al. (2021).

Citing Articles

Overcoming fixation and permeabilization challenges in flow cytometry by optical barcoding and multi-pass acquisition.

Fahlberg M, Forward S, Assita E, Mazzola M, Kiem A, Handley M bioRxiv. 2024; .

PMID: 39185194 PMC: 11343140. DOI: 10.1101/2024.08.13.607771.

References
1.
Krutzik P, Nolan G . Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry A. 2003; 55(2):61-70. DOI: 10.1002/cyto.a.10072. View

2.
Jutte B, Krollmann C, Cieslak K, Koerber R, Boor P, Graef C . Intercellular cGAMP transmission induces innate immune activation and tissue inflammation in Trex1 deficiency. iScience. 2021; 24(8):102833. PMC: 8326191. DOI: 10.1016/j.isci.2021.102833. View

3.
Teichmann L, Cullen J, Kashgarian M, Dong C, Craft J, Shlomchik M . Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ inflammation in lupus. Immunity. 2015; 42(3):552-65. PMC: 4456685. DOI: 10.1016/j.immuni.2015.02.015. View

4.
Maecker H, Trotter J . Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A. 2006; 69(9):1037-42. DOI: 10.1002/cyto.a.20333. View

5.
Hulspas R, OGorman M, Wood B, Gratama J, Sutherland D . Considerations for the control of background fluorescence in clinical flow cytometry. Cytometry B Clin Cytom. 2009; 76(6):355-64. DOI: 10.1002/cyto.b.20485. View